BMRN ▼ -0.9% - BioMarin Pharmaceutical Inc. $BMRN BMRN - BioMarin Announces Global Settlement with Ascendis Pharma A/S; Ascendis Will Pay Royalties to BioMarin on Yuviwel Sales in U.S., EU, Brazil and South Korea BioMarin Pharmaceutical shares declined 0.9% following the company's announcement of a global settlement with Ascendis Pharma regarding royalties on Yuviwel sales. Under the agreement, Ascendis will pay BioMarin royalties on Yuviwel revenues in the U.S., EU, Brazil, and South Korea. While the settlement establishes a new revenue stream for BioMarin, investors may have been disappointed by the lack of specifics around royalty rates or financial impact, or may have preferred alternative outcomes from the dispute. 31-AUG-2026 02:00 AM ET